CoChat
Sign Up
Cited by 48

Cell type–specific microRNA therapies for myocardial infarction

Liu, Bohao, Wang, Bryan, Zhang, Xiaokan, Lock, Roberta, Nash, Trevor, Vunjak-Novakovic, Gordana·2021·Science Translational Medicine
DOI 10.1126/scitranslmed.abd0914PMC PMC8848299
Open this paper in CoChat — free account

Abstract

microRNA-based therapies for myocardial infarction have opportunities and limitations on the basis of the target cell type and molecular pathways.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1126/scitranslmed.abd0914

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Nuc-Lys-5'-half was recently reported to regulate neuronal ferroptosis in the context of botulinum intoxication.

    “Interestingly, Nuc-Lys-5'-half was recently reported to regulate neuronal ferroptosis in the context of botulinum intoxication 27 .”

    From Human brain microRNAs exhibit cell-type specificity and age dependence (2026) · cites this paper as [27]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 281

  1. [2]Hunt SA, Taking heart—cardiac transplantation past, present, and future. N. Engl. J. Med 355, 231– 235 (2006). 16855261
  2. [3]Prabhu SD, Frangogiannis NG, The biological basis for cardiac repair after myocardial infarction: From inflammation to fibrosis. Circ. Res 119, 91– 112 (2016). 27340270 PMC4922528
  3. [4]Ghildiyal M, Zamore PD, Small silencing RNAs: An expanding universe. Nat. Rev. Genet 10, 94– 108 (2009). 19148191 PMC2724769
  4. [5]Bartel DP, MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116, 281– 297 (2004). 14744438
  5. [6]Olson EN, MicroRNAs as therapeutic targets and biomarkers of cardiovascular disease. Sci. Transl. Med 6, 239ps3 (2014). PMC4279862 24898744
  6. [7]Frampton AE, Castellano L, Colombo T, Giovannetti E, Krell J, Jacob J, Pellegrino L, Roca-Alonso L, Funel N, Gall TMH, De Giorgio A, Pinho FG, Fulci V, Britton DJ, Ahmad R, Habib NA, Coombes RC, Harding V, Knösel T, Stebbing J, Jiao LR, MicroRNAs cooperatively inhibit a network of tumor suppressor genes to promote pancreatic tumor growth and progression. Gastroenterology 146, 268– 277.e18 (2014). 24120476
  7. [8]Yellon DM, Hausenloy DJ, Myocardial reperfusion injury. N. Engl. J. Med 357, 1121 (2007). 17855673
  8. [9]Elmore S, Apoptosis: A review of programmed cell death. Toxicol. Pathol 35, 495– 516 (2007). 17562483 PMC2117903
  9. [10]Kubli DA, Gustafsson ÅB, Cardiomyocyte health: Adapting to metabolic changes through autophagy. Trends Endocrinol. Metab 25, 156– 164 (2014). 24370004 PMC3951169
  10. [11]Senyo SE, Steinhauser ML, Pizzimenti CL, Yang VK, Cai L, Wang M, Wu T-D, Guerquin-Kern J-L, Lechene CP, Lee RT, Mammalian heart renewal by pre-existing cardiomyocytes. Nature 493, 433– 436 (2013). 23222518 PMC3548046
  11. [12]Wang J, Liu S, Heallen T, Martin JF, The Hippo pathway in the heart: Pivotal roles in development, disease, and regeneration. Nat. Rev. Cardiol 15, 672– 684 (2018). 30111784
  12. [13]Wei K, Serpooshan V, Hurtado C, Diez-Cuñado M, Zhao M, Maruyama S, Zhu W, Fajardo G, Noseda M, Nakamura K, Tian X, Liu Q, Wang A, Matsuura Y, Bushway P, Cai W, Savchenko A, Mahmoudi M, Schneider MD, van den Hoff MJB, Butte MJ, Yang PC, Walsh K, Zhou B, Bernstein D, Mercola M, Ruiz-Lozano P, Epicardial FSTL1 reconstitution regenerates the adult mammalian heart. Nature 525, 479– 485 (2015). 26375005 PMC4762253
  13. [14]Liu Y, Zhang W, The role of HOPX in normal tissues and tumor progression. Biosci. Rep 40, BSR20191953 (2020). 31934721 PMC6997107
  14. [15]Morrow DA, Myocardial Infarction: A Companion to Braunwald’s Heart Disease (Elsevier, 2016).
  15. [16]Wang J-X, Jiao J-Q, Li Q, Long B, Wang K, Liu J-P, Li Y-R, Li P-F, MiR-499 regulates mitochondrial dynamics by targeting calcineurin and dynamin-related protein-1. Nat. Med 17, 71– 78 (2011). 21186368
  16. [17]Wang K, Gan T-Y, Li N, Liu C-Y, Zhou L-Y, Gao J-N, Chen C, Yan K-W, Ponnusamy M, Zhang Y-H, Li P-F, Circular RNA mediates cardiomyocyte death via miRNA-dependent upregulation of MTP18 expression. Cell Death Differ. 24, 1111– 1120 (2017). 28498369 PMC5442477
  17. [18]Wang K, Liu C-Y, Zhang X-J, Feng C, Zhou L-Y, Zhao Y, Li P-F, MiR-361-regulated prohibitin inhibits mitochondrial fission and apoptosis and protects heart from ischemia injury. Cell Death Differ. 22, 1058– 1068 (2015). 25501599 PMC4423187
  18. [19]Wang K, Long B, Zhou L-Y, Liu F, Zhou Q-Y, Liu C-Y, Fan Y-Y, Li P-F, CARL lncRNA inhibits anoxia-induced mitochondrial fission and apoptosis in cardiomyocytes by impairing miR-539-dependent PHB2 downregulation. Nat. Commun 5, 3596 (2014). 24710105
  19. [20]Wang K, Zhou L-Y, Wang J-X, Wang Y, Sun T, Zhao B, Yang Y-J, An T, Long B, Li N, Liu C-Y, Gong Y, Gao J-N, Dong Y-H, Zhang J, Li P-F, E2F1-dependent MIR-421 regulates mitochondrial fragmentation and myocardial infarction by targeting Pink1. Nat. Commun 6, 7619 (2015). 26184432
  20. [21]Hang P, Sun C, Guo J, Zhao J, Du Z, BDNF-mediates down-regulation of microRNA-195 inhibits ischemic cardiac apoptosis in rats. Int. J. Biol. Sci 12, 979– 989 (2016). 27489501 PMC4971736
  21. [22]Tang Y, Zheng J, Sun Y, Wu Z, Liu Z, Huang G, MicroRNA-1 regulates cardiomyocyte apoptosis by targeting Bcl-2. Int. Heart J 50, 377– 387 (2009). 19506341
  22. [23]Yang W, Han Y, Yang C, Chen Y, Zhao W, Su X, Yang K, Jin W, MicroRNA-19b-1 reverses ischaemia-induced heart failure by inhibiting cardiomyocyte apoptosis and targeting Bcl2 l11/BIM. Heart Vessels 34, 1221– 1229 (2019). 30607541
  23. [24]Qian L, Van Laake LW, Huang Y, Liu S, Wendland MF, Srivastava D, miR-24 inhibits apoptosis and represses Bim in mouse cardiomyocytes. J. Exp. Med 208, 549– 560 (2011). 21383058 PMC3058576
  24. [25]Bayoumi AS, Park K-M, Wang Y, Teoh J-P, Aonuma T, Tang Y, Su H, Weintraub NL, Kim L-M, A carvedilol-responsive microRNA, miR-125b-5p protects the heart from acute myocardial infarction by repressing pro-apoptotic bak1 and klf13 in cardiomyocytes. J. Mol. Cell. Cardiol 114, 72– 82 (2018). 29122578 PMC5800989
  25. [26]Song S, Seo H-H, Lee S-Y, Lee CY, Lee J, Yoo K-J, Yoon C, Choi E, Hwang K-C, Lee S, MicroRNA-17-mediated down-regulation of apoptotic protease activating factor 1 attenuates apoptosome formation and subsequent apoptosis of cardiomyocytes. Biochem. Biophys. Res. Commun 465, 299– 304 (2015). 26265044
  26. [27]Li Y, Ren S, Xia J, Wei Y, Xi Y, EIF4A3-induced circ-BNIP3 aggravated hypoxia-induced injury of H9c2 cells by targeting miR-27a-3p/BNIP3. Mol. Ther. Nucleic Acids 19, 533– 545 (2020). 31923741 PMC6951839
  27. [28]He S-F, Zhu H-J, Han Z-Y, Wu H, Jin S-Y, Irwin MG, Zhang Y, MicroRNA-133b-5p is involved in cardioprotection of morphine preconditioning in rat cardiomyocytes by targeting fas. Can. J. Cardiol 32, 996– 1007 (2016). 26919791
  28. [29]Wang Y, Tian M-M, Mi C-J, Chen K-L, Ji Y-C, Wang L, Zhang J, Cheng K, Exercise protects the heart against myocardial infarction through upregulation of miR-1192. Biochem. Biophys. Res. Commun 521, 1061– 1069 (2019). 31733833
  29. [30]Li Q, Yang J, Zhang J, Liu X-W, Yang C-J, Fan Z-X, Wang H-B, Yang Y, Zheng T, Yang J, Inhibition of microRNA-327 ameliorates ischemia/reperfusion injury-induced cardiomyocytes apoptosis through targeting apoptosis repressor with caspase recruitment domain. J. Cell. Physiol 235, 3753– 3767 (2020). 31587299 PMC13482720
  30. [31]Franke TF, Hornik CP, Segev L, Shostak GA, Sugimoto C, PI3K/Akt and apoptosis: Size matters. Oncogene 22, 8983– 8998 (2003). 14663477
  31. [32]Zhao L, Yang XR, Han X, MicroRNA-146b induces the Pi3k/Akt/NF-κB signaling pathway to reduce vascular inflammation and apoptosis in myocardial infarction by targeting PTEN. Exp. Ther. Med 17, 1171– 1181 (2019). 30679990 PMC6328856
  32. [34]Xing X, Guo S, Zhang G, Liu Y, Bi S, Wang X, Lu Q, miR-26a-5p protects against myocardial ischemia/reperfusion injury by regulating the PTEN/PI3K/AKT signaling pathway. Braz. J. Med. Biol. Res 53, e9106 (2020). 31994603 PMC6984371
  33. [35]Ke Z-P, Xu P, Shi Y, Gao A-M, MicroRNA-93 inhibits ischemia-reperfusion induced cardiomyocyte apoptosis by targeting PTEN. Oncotarget 7, 28796– 28805 (2016). 27119510 PMC5045357
  34. [36]Song C-L, Liu B, Diao H-Y, Shi Y-F, Zhang J-C, Li Y-X, Liu N, Yu Y-P, Wang G, Wang J-P, Li Q, Down-regulation of microRNA-320 suppresses cardiomyocyte apoptosis and protects against myocardial ischemia and reperfusion injury by targeting IGF-1. Oncotarget 7, 39740– 39757 (2016). 27175593 PMC5129967
  35. [37]Sun R, Zhang L, Long non-coding RNA MALAT1 regulates cardiomyocytes apoptosis after hypoxia/reperfusion injury via modulating miR-200a-3p/PDCD4 axis. Biomed. Pharmacother 111, 1036– 1045 (2019). 30841417
  36. [38]Luther KM, Haar L, Guinness MM, Wang Y, Lynch TL IV, Phan A, Song Y, Shen Z, Gardner G, Kuffel G, Ren X, Zilliox MJ, Jones WK, Exosomal miR-21a-5p mediates cardioprotection by mesenchymal stem cells. J. Mol. Cell. Cardiol 119, 125– 137 (2018). 29698635
  37. [39]Gu H, Liu Z, Li Y, Xie Y, Yao J, Zhu Y, Xu J, Dai Q, Zhong C, Zhu H, Ding S, Zhou L, Serum-derived extracellular vesicles protect against acute myocardial infarction by regulating miR-21/PDCD4 signaling pathway. Front. Physiol 9, 348 (2018). 29674977 PMC5895646
  38. [41]Wang J, Jia Z, Zhang C, Sun M, Wang W, Chen P, Ma K, Zhang Y, Li X, Zhou C, miR-499 protects cardiomyocytes from H2O2-induced apoptosis via its effects on Pdcd4 and Pacs2. RNA Biol. 11, 339– 350 (2014). 24646523 PMC4075519
  39. [42]Ma J, Zhang J, Wang Y, Long K, Wang X, Jin L, Tang Q, Zhu L, Tang G, Li X, Li M, MiR-532-5p alleviates hypoxia-induced cardiomyocyte apoptosis by targeting PDCD4. Gene 675, 36– 43 (2018). 29958954
  40. [43]Pan Z, Sun X, Ren J, Li X, Gao X, Lu C, Zhang Y, Sun H, Wang Y, Wang H, Wang J, Xie L, Lu Y, Yang B, miR-1 exacerbates cardiac ischemia-reperfusion injury in mouse models. PLOS ONE 7, e50515 (2012). 23226300 PMC3511560
  41. [44]Hong H, Tao T, Chen S, Liang C, Qiu Y, Zhou Y, Zhang R, MicroRNA-143 promotes cardiac ischemia-mediated mitochondrial impairment by the inhibition of protein kinase Cepsilon. Basic Res. Cardiol 112, 60 (2017). 28887629
  42. [45]Wang Y, Men M, Yang W, Zheng H, Xue S, MiR-31 downregulation protects against cardiac ischemia/reperfusion injury by targeting protein kinase C epsilon (PKCε) directly. Cell. Physiol. Biochem 36, 179– 190 (2015). 25925791
  43. [46]Meng X, Ji Y, Wan Z, Zhao B, Feng C, Zhao J, Li H, Song Y, Inhibition of miR-363 protects cardiomyocytes against hypoxia-induced apoptosis through regulation of Notch signaling. Biomed. Pharmacother 90, 509– 516 (2017). 28402919
  44. [47]Xu H, Jin L, Chen Y, Li J, Downregulation of microRNA-429 protects cardiomyocytes against hypoxia-induced apoptosis by increasing Notch1 expression. Int. J. Mol. Med 37, 1677– 1685 (2016). 27082497
  45. [48]Chen Z, Su X, Shen Y, Jin Y, Luo T, Kim I-M, Weintraub NL, Tang Y, MiR322 mediates cardioprotection against ischemia/reperfusion injury via FBXW7/notch pathway. J. Mol. Cell. Cardiol 133, 67– 74 (2019). 31150734 PMC6629474
  46. [49]Yan K, An T, Zhai M, Huang Y, Wang Q, Wang Y, Zhang R, Wang T, Liu J, Zhang Y, Zhang J, Wang K, Mitochondrial miR-762 regulates apoptosis and myocardial infarction by impairing ND2. Cell Death Dis. 10, 500 (2019). 31235686 PMC6591419
  47. [50]Lin D, Cui B, Ma J, Ren J, MiR-183-5p protects rat hearts against myocardial ischemia/reperfusion injury through targeting VDAC1. Biofactors 46, 83– 93 (2020). 31618500
  48. [51]Su Q, Liu Y, Lv X-W, Dai R-X, Yang X-H, Kong B-H, LncRNA TUG1 mediates ischemic myocardial injury by targeting miR-132-3p/HDAC3 axis. Am. J. Physiol. Circ. Physiol 318, H332– H344 (2020). 31858814
  49. [52]Shin S, Choi J-W, Moon H, Lee CY, Park J-H, Lee J, Seo H-H, Han G, Lim S, Lee S, Kim SW, Hwang K-C, Simultaneous suppression of multiple programmed cell death pathways by miRNA-105 in cardiac ischemic injury. Mol. Ther. Nucleic Acids 14, 438– 449 (2019). 30743213 PMC6369328
  50. [53]Wang K, Liu F, Liu C-Y, An T, Zhang J, Zhou L-Y, Wang M, Dong Y-H, Li N, Gao J-N, Zhao Y-F, Li P-F, The long noncoding RNA NRF regulates programmed necrosis and myocardial injury during ischemia and reperfusion by targeting miR-873. Cell Death Differ. 23, 1394– 1405 (2016). 27258785 PMC4947670
  51. [54]Qin D, Wang X, Li Y, Yang L, Wang R, Peng J, Essandoh K, Mu X, Peng T, Han Q, Yu K-J, Fan G-C, MicroRNA-223-5p and −3p cooperatively suppress necroptosis in ischemic/reperfused hearts. J. Biol. Chem 291, 20247– 20259 (2016). 27502281 PMC5025706
  52. [55]Wang J-X, Zhang X-J, Li Q, Wang K, Wang Y, Jiao J-Q, Feng C, Teng S, Zhou L-Y, Gong Y, Zhou Z-X, Liu J, Wang J-L, Li P.-f., MicroRNA-103/107 regulate programmed necrosis and myocardial ischemia/reperfusion injury through targeting FADD. Circ. Res 117, 352– 363 (2015). 26038570
  53. [56]Wang K, Liu F, Zhou L-Y, Ding S-L, Long B, Liu C-Y, Sun T, Fan Y-Y, Sun L, Li P-F, MiR-874 regulates myocardial necrosis by targeting caspase-8. Cell Death Dis. 4, e709 (2013). 23828572 PMC3730407
  54. [57]Wang K, Liu C-Y, Zhou L-Y, Wang J-X, Wang M, Zhao B, Zhao W-K, Xu S-J, Fan L-H, Zhang X-J, Feng C, Wang C-Q, Zhao Y-F, Li P-F, APF lncRNA regulates autophagy and myocardial infarction by targeting miR-188-3p. Nat. Commun 6, 6779 (2015). 25858075
  55. [58]Liu J, Jiang M, Deng S, Lu J, Huang H, Zhang Y, Gong P, Shen X, Ruan H, Jin M, Wang H, miR-93-5p-containing exosomes treatment attenuates acute myocardial infarction-induced myocardial damage. Mol. Ther. Nucleic Acids 11, 103– 115 (2018). 29858047 PMC5852413
  56. [61]Su Q, Liu Y, Lv X-W, Ye Z-L, Sun Y-H, Kong B-H, Qin Z-B, Inhibition of lncRNA TUG1 upregulates miR-142-3p to ameliorate myocardial injury during ischemia and reperfusion via targeting HMGB1- and Rac1-induced autophagy. J. Mol. Cell. Cardiol 133, 12– 25 (2019). 31145943
  57. [62]Hu S, Cao S, Tong Z, Liu J, FGF21 protects myocardial ischemia-reperfusion injury through reduction of miR-145-mediated autophagy. Am. J. Transl. Res 10, 3677– 3688 (2018). 30662618 PMC6291727
  58. [63]Chen Q, Zhou Y, Richards AM, Wang P, Up-regulation of miRNA-221 inhibits hypoxia/reoxygenation-induced autophagy through the DDIT4/mTORC1 and Tp53inp1/p62 pathways. Biochem. Biophys. Res. Commun 474, 168– 174 (2016). 27105917
  59. [64]Li Y, Yang R, Guo B, Zhang H, Zhang H, Liu S, Li Y, Exosomal miR-301 derived from mesenchymal stem cells protects myocardial infarction by inhibiting myocardial autophagy. Biochem. Biophys. Res. Commun 514, 323– 328 (2019). 31036323
  60. [65]Lin B, Feng D, Xu J, Cardioprotective effects of microRNA-18a on acute myocardial infarction by promoting cardiomyocyte autophagy and suppressing cellular senescence via brain derived neurotrophic factor. Cell Biosci. 9, 38 (2019). 31168354 PMC6509849
  61. [66]Li Z, Song Y, Liu L, Hou N, An X, Zhan D, Li Y, Zhou L, Li P, Yu L, Xia J, Zhang Y, Wang J, Yang X, MiR-199a impairs autophagy and induces cardiac hypertrophy through mTOR activation. Cell Death Differ. 24, 1205– 1213 (2017). 26160071 PMC5520159
  62. [67]Yang Y, Li Y, Chen X, Cheng X, Liao Y, Yu X, Exosomal transfer of miR-30a between cardiomyocytes regulates autophagy after hypoxia. J. Mol. Med 94, 711– 724 (2016). 26857375
  63. [68]Guo X, Wu X, Han Y, Tian E, Cheng J, LncRNA MALAT1 protects cardiomyocytes from isoproterenol-induced apoptosis through sponging miR-558 to enhance ULK1-mediated protective autophagy. J. Cell. Physiol 234, 10842– 10854 (2019). 30536615
  64. [71]Torrini C, Cubero RJ, Dirkx E, Braga L, Ali H, Prosdocimo G, Gutierrez MI, Collesi C, Licastro D, Zentilin L, Mano M, Zacchigna S, Vendruscolo M, Marsili M, Samal A, Giacca M, Common regulatory pathways mediate activity of microRNAs inducing cardiomyocyte proliferation. Cell Rep. 27, 2759– 2771.e5 (2019). 31141697 PMC6547019
  65. [72]Gabisonia K, Prosdocimo G, Aquaro GD, Carlucci L, Zentilin L, Secco I, Ali H, Braga L, Gorgodze N, Bernini F, Burchielli S, Collesi C, Zandonà L, Sinagra G, Piacenti M, Zacchigna S, Bussani R, Recchia FA, Giacca M, MicroRNA therapy stimulates uncontrolled cardiac repair after myocardial infarction in pigs. Nature 569, 418– 422 (2019). 31068698 PMC6768803
  66. [73]Xiao Y, Zhang Y, Chen Y, Li J, Zhang Z, Sun Y, Shen H, Zhao Z, Huang Z, Zhang W, Chen W, Shen Z, Inhibition of microRNA-9-5p protects against cardiac remodeling following myocardial infarction in mice. Hum. Gene Ther 30, 286– 301 (2019). 30101604
  67. [74]Yang Y, Cheng H-W, Qiu Y, Dupee D, Noonan M, Lin Y-D, Fisch S, Unno K, Sereti K-I, Liao R, MicroRNA-34a plays a key role in cardiac repair and regeneration following myocardial infarction. Circ. Res 117, 450– 459 (2015). 26082557 PMC4769861
  68. [75]Hu Y, Jin G, Li B, Chen Y, Zhong L, Chen G, Chen X, Zhong J, Liao W, Liao Y, Wang Y, Bin J, Suppression of miRNA let-7i-5p promotes cardiomyocyte proliferation and repairs heart function post injury by targetting CCND2 and E2F2. Clin. Sci 133, 425– 441 (2019). 30679264
  69. [76]Borden A, Kurian J, Nickoloff E, Yang Y, Troupes CD, Ibetti J, Lucchese AM, Gao E, Mohsin S, Koch WJ, Houser SR, Kishore R, Khan M, Transient introduction of miR-294 in the heart promotes cardiomyocyte cell cycle reentry after injury. Circ. Res 125, 14– 25 (2019). 30964391 PMC6586499
  70. [77]Huang W, Feng Y, Liang J, Yu H, Wang C, Wang B, Wang M, Jiang L, Meng W, Cai W, Medvedovic M, Chen J, Paul C, Davidson WS, Sadayappan S, Stambrook PJ, Yu X-Y, Wang Y, Loss of microRNA-128 promotes cardiomyocyte proliferation and heart regeneration. Nat. Commun 9, 700 (2018). 29453456 PMC5816015
  71. [78]Zhang J, Wu L, Li Z, Fu G, miR-1231 exacerbates arrhythmia by targeting calciumchannel gene CACNA2D2 in myocardial infarction. Am. J. Transl. Res 9, 1822– 1833 (2017). 28469787 PMC5411930
  72. [79]Liu X, Zhang Y, Du W, Liang H, He H, Zhang L, Pan Z, Li X, Xu C, Zhou Y, Wang L, Qian M, Liu T, Yin H, Lu Y, Yang B, Shan H, MiR-223-3p as a novel microRNA regulator of expression of voltage-gated K+ Channel Kv4.2 in acute myocardial infarction. Cell. Physiol. Biochem 39, 102– 114 (2016). 27322747
  73. [80]Zhou X, Sun F, Luo S, Zhao W, Yang T, Zhang G, Gao M, Lu R, Shu Y, Mu W, Zhuang Y, Ding F, Xu C, Lu Y, Let-7a is an antihypertrophic regulator in the heart via targeting calmodulin. Int. J. Biol. Sci 13, 22– 31 (2017). 28123343 PMC5264258
  74. [81]Yang Y, Del Re DP, Nakano N, Sciarretta S, Zhai P, Park J, Sayed D, Shirakabe A, Matsushima S, Park Y, Tian B, Abdellatif M, Sadoshima J, MIR-206 mediates YAP-induced cardiac hypertrophy and survival. Circ. Res 117, 891– 904 (2015). 26333362 PMC4747867
  75. [82]Yang J, Hu F, Fu X, Jiang Z, Zhang W, Chen K, MiR-128/SOX7 alleviates myocardial ischemia injury by regulating IL-33/sST2 in acute myocardial infarction. Biol. Chem 400, 533– 544 (2019). 30265647
  76. [83]Li A, Yu Y, Ding X, Qin Y, Jiang Y, Wang X, Liu G, Chen X, Yue E, Sun X, Zahra SM, Yan Y, Ren L, Wang S, Chai L, Bai Y, Yang B, MiR-135b protects cardiomyocytes from infarction through restraining the NLRP3/caspase-1/IL-1β pathway. Int. J. Cardiol 307, 137– 145 (2019). 31870781
  77. [84]Yuan M, Zhang L, You F, Zhou J, Ma Y, Yang F, Tao L, MiR-145-5p regulates hypoxia-induced inflammatory response and apoptosis in cardiomyocytes by targeting CD40. Mol. Cell. Biochem 431, 123– 131 (2017). 28281187
  78. [85]Turner NA, Das A, Warburton P, O’Regan DJ, Ball SG, Porter KE, Interleukin-1α stimulates proinflammatory cytokine expression in human cardiac myofibroblasts. Am. J. Physiol. Hear. Circ. Physiol 297, H1117– H1127 (2009). 19648252
  79. [86]Kawaguchi M, Takahashi M, Hata T, Kashima Y, Usui F, Morimoto H, Izawa A, Takahashi Y, Masumoto J, Koyama J, Hongo M, Noda T, Nakayama J, Sagara J, Taniguchi S, Ikeda U, Inflammasome activation of cardiac fibroblasts is essential for myocardial ischemia/reperfusion injury. Circulation 123, 594– 604 (2011). 21282498
  80. [87]Lindsey ML, Zamilpa R, Temporal and spatial expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases following myocardial infarction. Cardiovasc. Ther 30, 31– 41 (2012). 20645986 PMC2972388
  81. [88]Lijnen PJ, Petrov VV, Fagard RH, Induction of cardiac fibrosis by transforming growth factor-β1. Mol. Genet. Metab 71, 418– 435 (2000). 11001836
  82. [89]Sun Y, Zhang JQ, Zhang J, Ramires FJA, Angiotensin II, transforming growth factor-β1 and repair in the infarcted heart. J. Mol. Cell. Cardiol 30, 1559– 1569 (1998). 9737942
  83. [90]Ye H, Cai P-C, Zhou Q, Ma W-L, Transforming growth factor-β1 suppresses the up-regulation of matrix metalloproteinase-2 by lung fibroblasts in response to tumor necrosis factor-α. Wound Repair Regen. 19, 392– 399 (2011). 21518085
  84. [91]Li A-H, Liu PP, Villarreal FJ, Garcia RA, Dynamic changes in myocardial matrix and relevance to disease: Translational perspectives. Circ. Res 114, 916– 927 (2014). 24577970
  85. [92]Nagaraju CK, Dries E, Popovic N, Singh AA, Haemers P, Roderick HL, Claus P, Sipido KR, Driesen RB, Global fibroblast activation throughout the left ventricle but localized fibrosis after myocardial infarction. Sci. Rep 7, 10801 (2017). 28883544 PMC5589875
  86. [93]Frangogiannis NG, Michael LH, Entman ML, Myofibroblasts in reperfused myocardial infarcts express the embryonic form of smooth muscle myosin heavy chain (SMemb). Cardiovasc. Res 48, 89– 100 (2000). 11033111
  87. [95]Nagaraju CK, Robinson EL, Abdesselem M, Trenson S, Dries E, Gilbert G, Janssens S, Van Cleemput J, Rega F, Meyns B, Roderick HL, Driesen RB, Sipido KR, Myofibroblast phenotype and reversibility of fibrosis in patients with end-stage heart failure. J. Am. Coll. Cardiol 73, 2267– 2282 (2019). 31072570
  88. [96]Pan Z, Sun X, Shan H, Wang N, Wang J, Ren J, Feng S, Xie L, Lu C, Yuan Y, Zhang Y, Wang Y, Lu Y, Yang B, miR-101 inhibited post-infarct cardiac fibrosis and improved left ventricular compliance via FOS/TGFβ1 pathway. Circulation 126, 840– 850 (2012). 22811578
  89. [97]Zhao X, Wang K, Liao Y, Zeng Q, Li Y, Hu F, Liu Y, Meng K, Qian C, Zhang Q, Guan H, Feng K, Zhou Y, Du Y, Chen Z, MicroRNA-101a inhibits cardiac fibrosis induced by hypoxia via targeting TGF RI on cardiac fibroblasts. Cell. Physiol. Biochem 35, 213– 226 (2015). 25591764
  90. [98]Tao L, Bei Y, Chen P, Lei Z, Fu S, Zhang H, Xu J, Che L, Chen X, Sluijter JPG, Das S, Cretoiu D, Xu B, Zhong J, Xiao J, Li X, Crucial role of miR-433 in regulating cardiac fibrosis. Theranostics 6, 2068– 2083 (2016). 27698941 PMC5039681
  91. [99]Wang J, Huang W, Xu R, Nie Y, Cao X, Meng J, Xu X, Hu S, Zheng Z, MicroRNA-24 regulates cardiac fibrosis after myocardial infarction. J. Cell. Mol. Med 16, 2150– 2160 (2012). 22260784 PMC3822985
  92. [100]Hong Y, Cao H, Wang Q, Ye J, Sui L, Feng J, Cai X, Song H, Zhang X, Chen X, MiR-22 may suppress fibrogenesis by targeting TGFβR I in cardiac fibroblasts. Cell. Physiol. Biochem 40, 1345– 1353 (2016). 27997889
  93. [101]Liang H, Zhang C, Ban T, Liu Y, Mei L, Piao X, Zhao D, Lu Y, Chu W, Yang B, A novel reciprocal loop between microRNA-21 and TGFβRIII is involved in cardiac fibrosis. Int. J. Biochem. Cell Biol 44, 2152– 2160 (2012). 22960625
  94. [102]Du W, Liang H, Gao X, Li X, Zhang Y, Pan Z, Li C, Wang Y, Liu Y, Yuan W, Ma N, Chu W, Shan H, Lu Y, MicroRNA-328, a potential anti-fibrotic target in cardiac interstitial fibrosis. Cell. Physiol. Biochem 39, 827– 836 (2016). 27497782
  95. [103]Yuan J, Chen H, Ge D, Xu Y, Xu H, Yang Y, Gu M, Zhou Y, Zhu J, Ge T, Chen Q, Gao Y, Wang Y, Li X, Zhao Y, Mir-21 promotes cardiac fibrosis after myocardial infarction via targeting Smad7. Cell. Physiol. Biochem 42, 2207– 2219 (2017). 28817807
  96. [104]Huang Y, Qi Y, Du J-Q, Zhang D.-f., MicroRNA-34a regulates cardiac fibrosis after myocardial infarction by targeting Smad4. Expert Opin. Ther. Targets 18, 1355– 1365 (2014). 25322725
  97. [105]Wang X, Morelli MB, Matarese A, Sardu C, Santulli G, Cardiomyocyte-derived exosomal microRNA-92a mediates post-ischemic myofibroblast activation both in vitro and ex vivo. ESC Hear. Fail 7, 285– 289 (2020). PMC7083461 31981320
  98. [106]Morelli MB, Shu J, Sardu C, Matarese A, Santulli G, Cardiosomal microRNAs are essential in post-infarction myofibroblast phenoconversion. Int. J. Mol. Sci 21, 201 (2020). PMC6982041 31892162
  99. [107]Dorn LE, Petrosino JM, Wright P, Accornero F, CTGF/CCN2 is an autocrine regulator of cardiac fibrosis. J. Mol. Cell. Cardiol 121, 205– 211 (2018). 30040954 PMC6260782
  100. [108]Lipson KE, Wong C, Teng Y, Spong S, CTGF is a central mediator of tissue remodeling and fibrosis and its inhibition can reverse the process of fibrosis. Fibrogenesis Tissue Repair 5, S24 (2012). 23259531 PMC3368796
  101. [109]Duisters RF, Tijsen AJ, Schroen B, Leenders JJ, Lentink V, van der Made I, Herias V, van Leeuwen RE, Schellings MW, Barenbrug P, Maessen JG, Heymans S, Pinto YM, Creemers EE, miR-133 and miR-30 regulate connective tissue growth factor: Implications for a role of microRNAs in myocardial matrix remodeling. Circ. Res 104, 170– 178 (2009). 19096030
  102. [110]Chen L, Ji Q, Zhu H, Ren Y, Fan Z, Tian N, miR-30a attenuates cardiac fibrosis in rats with myocardial infarction by inhibiting CTGF. Exp. Ther. Med 15, 4318– 4324 (2018). 29849775 PMC5962866
  103. [112]Adam O, Löhfelm B, Thum T, Gupta SK, Puhl SL, Schäfers HJ, Böhm M, Laufs U, Role of miR-21 in the pathogenesis of atrial fibrosis. Basic Res. Cardiol 107, 278 (2012). 22760500
  104. [113]Cardin S, Guasch E, Luo X, Naud P, Quang KL, Shi YF, Tardif J-C, Comtois P, Nattel S, Role for MicroRNA-21 in atrial profibrillatory fibrotic remodeling associated with experimental postinfarction heart failure. Circ. Arrhythm. Electrophysiol 5, 1027– 1035 (2012). 22923342
  105. [114]Yuan X, Pan J, Wen L, Gong B, Li J, Gao H, Tan W, Liang S, Zhang H, Wang X, MiR-144-3p enhances cardiac fibrosis after myocardial infarction by targeting PTEN. Front. Cell Dev. Biol 7, 249 (2019). 31737623 PMC6828614
  106. [115]Boettger T, Beetz N, Kostin S, Schneider J, Krüger M, Hein L, Braun T, Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143/145 gene cluster. J. Clin. Invest 119, 2634– 2647 (2009). 19690389 PMC2735940
  107. [116]Li C, Li J, Xue K, Zhang J, Wang C, Zhang Q, Chen X, Gao C, Yu X, Sun L, MicroRNA-143-3p promotes human cardiac fibrosis via targeting sprouty3 after myocardial infarction. J. Mol. Cell. Cardiol 129, 281– 292 (2019). 30878395
  108. [117]Wang Y-S, Li S-H, Guo J, Mihic A, Wu J, Sun L, Davis K, Weisel RD, Li R-K, Role of miR-145 in cardiac myofibroblast differentiation. J. Mol. Cell. Cardiol 66, 94– 105 (2014). 24001939
  109. [118]Liu N, Bezprozvannaya S, Williams AH, Qi X, Richardson JA, Bassel-Duby R, Olson EN, microRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart. Genes Dev. 22, 3242– 3254 (2008). 19015276 PMC2600761
  110. [119]Boštjančič E, Zidar N, Štajer D, Glavač D, MicroRNAs miR-1, miR-133a, miR-133b and miR-208 are dysregulated in human myocardial infarction. Cardiology 115, 163– 169 (2010). 20029200
  111. [120]van Rooij E, Sutherland LB, Thatcher JE, DiMaio JM, Naseem RH, Marshall WS, Hill JA, Olson EN, Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc. Natl. Acad. Sci. U.S.A 105, 13027– 13032 (2008). 18723672 PMC2529064
  112. [121]Port JD, Walker LA, Polk J, Nunley K, Buttrick PM, Sucharov CC, Temporal expression of miRNAs and mRNAs in a mouse model of myocardial infarction. Physiol. Genomics 43, 1087– 1095 (2011). 21771878 PMC3217325
  113. [122]Castoldi G, Di Gioia CRT, Bombardi C, Catalucci D, Corradi B, Gualazzi MG, Leopizzi M, Mancini M, Zerbini G, Condorelli G, Stella A, MiR-133a regulates collagen 1A1: Potential role of miR-133a in myocardial fibrosis in angiotensin II-dependent hypertension. J. Cell. Physiol 227, 850– 856 (2012). 21769867
  114. [123]Sassi Y, Avramopoulos P, Ramanujam D, Grüter L, Werfel S, Giosele S, Brunner A-D, Esfandyari D, Papadopoulou AS, De Strooper B, Hübner N, Kumarswamy R, Thum T, Yin X, Mayr M, Laggerbauer B, Engelhardt S, Cardiac myocyte miR-29 promotes pathological remodeling of the heart by activating Wnt signaling. Nat. Commun 8, 1614 (2017). 29158499 PMC5696364
  115. [124]Xiang FL, Fang M, Yutzey KE, Loss of β-catenin in resident cardiac fibroblasts attenuates fibrosis induced by pressure overload in mice. Nat. Commun 8, 712 (2017). 28959037 PMC5620049
  116. [125]Chen M-H, Liu J-C, Liu Y, Hu Y-C, Cai X-F, Yin D-C, MicroRNA-199a regulates myocardial fibrosis in rats by targeting SFRP5. Eur. Rev. Med. Pharmacol. Sci 23, 3976– 3983 (2019). 31115026
  117. [126]Cui J, Qi S, Liao R, Su D, Wang Y, Xue S, MiR-574–5p promotes the differentiation of human cardiac fibroblasts via regulating ARID3A. Biochem. Biophys. Res. Commun 521, 427– 433 (2020). 31672272
  118. [127]Yuan X, Pan J, Wen L, Gong B, Li J, Gao H, Tan W, Liang S, Zhang H, Wang X, MiR-590-3p regulates proliferation, migration and collagen synthesis of cardiac fibroblast by targeting ZEB1. J. Cell. Mol. Med 24, 227– 237 (2020). 31675172 PMC6933374
  119. [128]Brutsaert DL, Cardiac endothelial-myocardial signaling: Its role in cardiac growth, contractile performance, and rhythmicity. Physiol. Rev 83, 59– 115 (2003). 12506127
  120. [129]Falque H, Bochaton T, Bernelin H, Paccalet A, Da Silva CC, Baetz D, Bonnefoy-Cudraz E, Mewton N, Ovize M, Endothelial activation and infarct size at the acute phase of myocardial infarction. Arch. Cardiovasc. Dis. Suppl 10, 178 (2018).
  121. [130]Hernández-Reséndiz S, Muñoz-Vega M, Contreras WE, Crespo-Avilan GE, Rodriguez-Montesinos J, Arias-Carrión O, Pérez-Méndez O, Boisvert WA, Preissner KT, Cabrera-Fuentes HA, Responses of endothelial cells towards ischemic conditioning following acute myocardial infarction. Cond. Med 1, 247– 258 (2018). 30338315 PMC6191189
  122. [131]Lindsey ML, Escobar GP, Dobrucki LW, Goshorn DK, Bouges S, Mingoia JT, McClister DM, Su H, Gannon J, MacGillivray C, Lee RT, Sinusas AJ, Spinale FG, Matrix metalloproteinase-9 gene deletion facilitates angiogenesis after myocardial infarction. Am. J. Physiol. Heart Circ. Physiol 290, H232– H239 (2006). 16126817
  123. [132]Fallah A, Sadeghinia A, Kahroba H, Samadi A, Heidari HR, Bradaran B, Zeinali S, Molavi O, Therapeutic targeting of angiogenesis molecular pathways in angiogenesis-dependent diseases. Biomed. Pharmacother 110, 775– 785 (2019). 30554116
  124. [133]Zhang Y, Qin W, Zhang L, Wu X, Du N, Hu Y, Li X, Shen N, Xiao D, Zhang H, Li Z, Zhang Y, Yang H, Gao F, Du Z, Xu C, Yang B, MicroRNA-26a prevents endothelial cell apoptosis by directly targeting TRPC6 in the setting of atherosclerosis. Sci. Rep 5, 9401 (2015). 25801675 PMC4371083
  125. [134]Qin B, Shu Y, Xiao L, Lu T, Lin Y, Yang H, Lu Z, MicroRNA-150 targets ELK1 and modulates the apoptosis induced by ox-LDL in endothelial cells. Mol. Cell. Biochem 429, 45– 58 (2017). 28110404
  126. [135]Chen P, Zhong J, Ye J, He Y, Liang Z, Cheng Y, Zheng J, Chen H, Chen C, miR-324-5p protects against oxidative stress-induced endothelial progenitor cell injury by targeting Mtfr1. J. Cell. Physiol 234, 22082– 22092 (2019). 31066044
  127. [136]Ghosh G, Subramanian IV, Adhikari N, Zhang X, Joshi HP, Basi D, Chandrashekhar YS, Hall JL, Roy S, Zeng Y, Ramakrishnan S, Hypoxia-induced microRNA-424 expression in human endothelial cells regulates HIF-α isoforms and promotes angiogenesis. J. Clin. Invest 120, 4141– 4154 (2010). 20972335 PMC2964978
  128. [137]Dai G-H, Ma P-Z, Song X-B, Liu N, Zhang T, Wu B, MicroRNA-223-3p inhibits the angiogenesis of ischemic cardiac microvascular endothelial cells via affecting RPS6KB1/hif-1a signal pathway. PLOS ONE 9, e108468 (2014). 25313822 PMC4196764
  129. [138]Fiedler J, Jazbutyte V, Kirchmaier BC, Gupta SK, Lorenzen J, Hartmann D, Galuppo P, Kneitz S, Pena JTG, Sohn-Lee C, Loyer X, Soutschek J, Brand T, Tuschl T, Heineke J, Martin U, Schulte-Merker S, Ertl G, Engelhardt S, Bauersachs J, Thum T, MicroRNA-24 regulates vascularity after myocardial infarction. Circulation 124, 720– 730 (2011). 21788589
  130. [139]Wang S, Aurora AB, Johnson BA, Qi X, Anally JM, Hill JA, Richardson JA, Bassel-Duby R, Olson EN, The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev. Cell 15, 261– 271 (2008). 18694565 PMC2685763
  131. [140]Ma T, Chen Y, Chen Y, Meng Q, Sun J, Shao L, Yu Y, Huang H, Hu Y, Yang Z, Yang J, Shen Z, MicroRNA-132, delivered by mesenchymal stem cell-derived exosomes, promote angiogenesis in myocardial infarction. Stem Cells Int. 2018, 3290372 (2018). 30271437 PMC6151206
  132. [141]Meloni M, Marchetti M, Garner K, Littlejohns B, Sala-Newby G, Xenophontos N, Floris I, Suleiman M-S, Madeddu P, Caporali A, Emanueli C, Local inhibition of microRNA-24 improves reparative angiogenesis and left ventricle remodeling and function in mice with myocardial infarction. Mol. Ther 21, 1390– 1402 (2013). 23774796 PMC3702112
  133. [142]Liu S, Chen J, Shi J, Zhou W, Wang L, Fang W, Zhong Y, Chen X, Chen Y, Sabri A, Liu S, M1-like macrophage-derived exosomes suppress angiogenesis and exacerbate cardiac dysfunction in a myocardial infarction microenvironment. Basic Res. Cardiol 115, 22 (2020). 32112145
  134. [143]Joris V, Gomez EL, Menchi L, Lobysheva I, Di Mauro V, Esfahani H, Condorelli G, Balligand J-L, Catalucci D, Dessy C, MicroRNA-199a-3p and MicroRNA-199a-5p take part to a redundant network of regulation of the NOS (NO Synthase)/NO pathway in the endothelium. Arterioscler. Thromb. Vasc. Biol 38, 2345– 2357 (2018). 29976767
  135. [144]Zhao X, Wei X, Wang X, Qi G, Long non-coding RNA NORAD regulates angiogenesis of human umbilical vein endothelial cells via miR-590-3p under hypoxic conditions. Mol. Med. Rep 21, 2560– 2570 (2020). 32323787 PMC7185274
  136. [145]Fan Z-G, Qu X-L, Chu P, Gao Y-L, Gao X-F, Chen S-L, Tian N-L, MicroRNA-210 promotes angiogenesis in acute myocardial infarction. Mol. Med. Rep 17, 5658– 5665 (2018). 29484401 PMC5866007
  137. [146]Wang N, Chen C, Yang D, Liao Q, Luo H, Wang X, Zhou F, Yang X, Yang J, Zeng C, Wang WE, Mesenchymal stem cells-derived extracellular vesicles, via miR-210, improve infarcted cardiac function by promotion of angiogenesis. Biochim. Biophys. Acta - Mol. Basis Dis 1863, 2085– 2092 (2017). 28249798
  138. [147]Gallant-Behm CL, Piper J, Dickinson BA, Dalby CM, Pestano LA, Jackson AL, A synthetic microRNA-92a inhibitor (MRG-110) accelerates angiogenesis and wound healing in diabetic and nondiabetic wounds. Wound Repair Regen. 26, 311– 323 (2018). 30118158
  139. [148]Bonauer A, Carmona G, Iwasaki M, Mione M, Koyanagi M, Fischer A, Burchfield J, Fox H, Doebele C, Ohtani K, Chavakis E, Potente M, Tjwa M, Urbich C, Zeiher AM, Dimmeler S, MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in Mice. Science 324, 1710– 1713 (2009). 19460962
  140. [149]Veliceasa D, Biyashev D, Qin G, Misener S, Mackie AR, Kishore R, Volpert OV, Therapeutic manipulation of angiogenesis with miR-27b. Vasc. Cell 7, 6 (2015). 26161255 PMC4497374
  141. [150]Li C-C, Qiu X-T, Sun Q, Zhou J-P, Yang H-J, Wu W-Z, He L-F, Tang C-E, Zhang G-G, Bai Y-P, Endogenous reduction of miR-185 accelerates cardiac function recovery in mice following myocardial infarction via targeting of cathepsin K. J. Cell. Mol. Med 23, 1164– 1173 (2019). 30450725 PMC6349160
  142. [151]Bayoumi AS, Teoh J-P, Aonuma T, Yuan Z, Ruan X, Tang Y, Su H, Weintraub NL, Kim I-M, MicroRNA-532 protects the heart in acute myocardial infarction, and represses prss23, a positive regulator of endothelial-to-mesenchymal transition. Cardiovasc. Res 113, 1603– 1614 (2017). 29016706 PMC5852516
  143. [152]Bartman CM, Oyama Y, Brodsky K, Khailova L, Walker L, Koeppen M, Eckle T, Wang M, Intense light-elicited upregulation of miR-21 facilitates glycolysis and cardioprotection through Per2-dependent mechanisms. PLOS ONE 12, e0176243 (2017). 28448534 PMC5407766
  144. [153]Liu RR, Li J, Gong JY, Kuang F, Liu JY, Zhang YS, Ma QL, Song CJ, Truax AD, Gao F, Yang K, Jin BQ, Chen LH, MicroRNA-141 regulates the expression level of ICAM-1 on endothelium to decrease myocardial ischemia-reperfusion injury. Am. J. Physiol. Circ. Physiol 309, H1303– H1313 (2015). 26371161
  145. [154]Yang L, Wang B, Zhou Q, Wang Y, Liu X, Liu Z, Zhan Z, MicroRNA-21 prevents excessive inflammation and cardiac dysfunction after myocardial infarction through targeting KBTBD7. Cell Death Dis. 9, 769 (2018). 29991775 PMC6039462
  146. [155]Gupta SK, Itagaki R, Zheng X, Batkai S, Thum S, Ahmad F, Van Aelst LN, Sharma A, Piccoli M-T, Weinberger F, Fiedler J, Heuser M, Heymans S, Falk CS, Förster R, Schrepfer S, Thum T, miR-21 promotes fibrosis in an acute cardiac allograft transplantation model. Cardiovasc. Res 110, 215– 226 (2016). 26865549
  147. [156]Li J, Cai SXX, He Q, Zhang H, Friedberg D, Wang F, Redington AN, Intravenous miR-144 reduces left ventricular remodeling after myocardial infarction. Basic Res. Cardiol 113, 36 (2018). 30084039
  148. [157]Xu H-M, Sui F-H, Sun M-H, Guo G-L, Downregulated microRNA-224 aggravates vulnerable atherosclerotic plaques and vascular remodeling in acute coronary syndrome through activation of the TGF-β/Smad pathway. J. Cell. Physiol 234, 2537– 2551 (2019). 30317569
  149. [158]Yang J, Brown ME, Zhang H, Martinez M, Zhao Z, Bhutani S, Yin S, Trac D, Xi JJ, Davis ME, High-throughput screening identifies microRNAs that target Nox2 and improve function after acute myocardial infarction. Am. J. Physiol. Hear. Circ. Physiol 312, H1002– H1012 (2017). PMC5451584 28235791
  150. [159]de Couto G, Gallet R, Cambier L, Jaghatspanyan E, Makkar N, Dawkins JF, Berman BP, Marbán E, Exosomal microRNA transfer into macrophages mediates cellular postconditioning. Circulation 136, 200– 214 (2017). 28411247 PMC5505791
  151. [160]Garikipati VNS, Verma SK, Jolardarashi D, Cheng Z, Ibetti J, Cimini M, Tang Y, Khan M, Yue Y, Benedict C, Nickoloff E, Truongcao MM, Gao E, Krishnamurthy P, Goukassian DA, Koch WJ, Kishore R, Therapeutic inhibition of miR-375 attenuates post-myocardial infarction inflammatory response and left ventricular dysfunction via PDK-1-AKT signalling axis. Cardiovasc. Res 113, 938– 949 (2017). 28371849 PMC11008084
  152. [161]Shao L, Zhang Y, Pan X, Liu B, Liang C, Zhang Y, Wang Y, Yan B, Xie W, Sun Y, Shen Z, Yu X-Y, Li Y, Knockout of beta-2 microglobulin enhances cardiac repair by modulating exosome imprinting and inhibiting stem cell-induced immune rejection. Cell. Mol. Life Sci 77, 937– 952 (2020). 31312880 PMC11104803
  153. [162]Zhao J, Li X, Hu J, Chen F, Qiao S, Sun X, Gao L, Xie J, Xu B, Mesenchymal stromal cell-derived exosomes attenuate myocardial ischaemia-reperfusion injury through miR-182-regulated macrophage polarization. Cardiovasc. Res 115, 1205– 1216 (2019). 30753344 PMC6529919
  154. [163]Bejerano T, Etzion S, Elyagon S, Etzion Y, Cohen S, Nanoparticle delivery of miRNA-21 mimic to cardiac macrophages improves myocardial remodeling after myocardial infarction. Nano Lett. 18, 5885– 5891 (2018). 30141949
  155. [164]Ye ZM, Yang S, Xia Y.-p., Hu R.-t., Chen S, Li B.-w., Chen S.-l., Luo X.-y., Mao L, Li Y, Jin H, Qin C, Hu B, LncRNA MIAT sponges miR-149-5p to inhibit efferocytosis in advanced atherosclerosis through CD47 upregulation. Cell Death Dis. 10, 138 (2019). 30755588 PMC6372637
  156. [165]Arif M, Pandey R, Alam P, Jiang S, Sadayappan S, Paul A, Ahmed RPH, MicroRNA-210-mediated proliferation, survival, and angiogenesis promote cardiac repair post myocardial infarction in rodents. J. Mol. Med 95, 1369– 1385 (2017). 28948298 PMC5941944
  157. [166]Hu S, Huang M, Li Z, Jia F, Ghosh Z, Lijkwan MA, Fasanaro P, Sun N, Wang X, Martelli F, Robbins RC, Wu JC, MicroRNA-210 as a novel therapy for treatment of ischemic heart disease. Circulation 122, S124– S131 (2010). 20837903 PMC2952325
  158. [167]Huang L, Guo B, Liu S, Miao C, Li Y, Inhibition of the LncRNA Gpr19 attenuates ischemia-reperfusion injury after acute myocardial infarction by inhibiting apoptosis and oxidative stress via the miR-324-5p/Mtfr1 axis. IUBMB Life 72, 373– 383 (2020). 31622017
  159. [168]Wang X, Zhang X, Ren X-P, Chen J, Liu H, Yang J, Medvedovic M, Hu Z, Fan G-C, MicroRNA-494 targeting both proapoptotic and antiapoptotic proteins protects against ischemia/reperfusion-induced cardiac injury. Circulation 122, 1308– 1318 (2010). 20837890 PMC2956502
  160. [169]Su Q, Lv X-W, Sun Y-H, Ye Z-L, Kong B-H, Qin Z-B, MicroRNA-494 inhibits the LRG1 expression to induce proliferation and migration of VECs in rats following myocardial infarction. Mol. Ther. Nucleic Acids 18, 110– 122 (2019). 31541797 PMC6796686
  161. [170]el Azzouzi H, Leptidis S, Dirkx E, Hoeks J, van Bree B, Brand K, McClellan EA, Poels E, Sluimer JC, van den Hoogenhof MMG, Armand AS, Yin X, Langley S, Bourajjaj M, Olieslagers S, Krishnan J, Vooijs M, Kurihara H, Stubbs A, Pinto YM, Krek W, Mayr M, Martins PADC, Schrauwen P, De Windt LJ, The hypoxia-inducible microRNA cluster miR-199a~214 targets myocardial PPARδ and impairs mitochondrial fatty acid oxidation. Cell Metab. 18, 341– 354 (2013). 24011070
  162. [171]Li Z, Liu L, Hou N, Song Y, An X, Zhang Y, Yang X, Wang J, miR-199-sponge transgenic mice develop physiological cardiac hypertrophy. Cardiovasc. Res 110, 258– 267 (2016). 26976621
  163. [172]Park K-M, Teoh J-P, Wang Y, Broskova Z, Bayoumi AS, Tang Y, Su H, Weintraub NL, Kim I.-m., Carvedilol-responsive microRNAs, miR-199a-3p and −214 protect cardiomyocytes from simulated ischemia-reperfusion injury. Am. J. Physiol. Circ. Physiol 311, H371– H383 (2016). PMC5005281 27288437
  164. [173]Chen L, Wang F-Y, Zeng Z-Y, Cui L, Shen J, Song X-W, Li P, Zhao X-X, Qin Y-W, MicroRNA-199a acts as a potential suppressor of cardiomyocyte autophagy through targeting Hspa5. Oncotarget 8, 63825– 63834 (2017). 28969032 PMC5609964
  165. [174]Hinkel R, Ramanujam D, Kaczmarek V, Howe A, Klett K, Beck C, Dueck A, Thum T, Laugwitz KL, Maegdefessel L, Weber C, Kupatt C, Engelhardt S, AntimiR-21 prevents myocardial dysfunction in a pig model of ischemia/reperfusion injury. J. Am. Coll. Cardiol 75, 1788– 1800 (2020). 32299591
  166. [175]Hu J, Huang C-X, Rao P-P, Zhou J-P, Wang X, Tang L, Liu M-X, Zhang G-G, Inhibition of microRNA-155 attenuates sympathetic neural remodeling following myocardial infarction via reducing M1 macrophage polarization and inflammatory responses in mice. Eur. J. Pharmacol 851, 122– 132 (2019). 30721702
  167. [176]Ye Y, Hu Z, Lin Y, Zhang C, Perez-Polo JR, Downregulation of microRNA-29 by antisense inhibitors and a PPAR-γ agonist protects against myocardial ischaemia–reperfusion injury. Cardiovasc. Res 87, 535– 544 (2010). 20164119
  168. [177]Guo Z-X, Zhou F-Z, Song W, Yu L-L, Yan W-J, Yin L-H, Sang H, Zhang H-Y, Suppression of microRNA-101 attenuates hypoxia-induced myocardial H9c2 cell injury by targeting DIMT1-Sp1/survivin pathway. Eur. Rev. Med. Pharmacol. Sci 22, 6965– 6976 (2018). 30402863
  169. [178]Wang C, Zhang C, Liu L, Xi A, Chen B, Li Y, Du J, Macrophage-derived mir-155-containing exosomes suppress fibroblast proliferation and promote fibroblast inflammation during cardiac injury. Mol. Ther 25, 192– 204 (2017). 28129114 PMC5363311
  170. [179]Guo J, Liu H-B, Sun C, Yan X-Q, Hu J, Yu J, Yuan Y, Du Z-M, MicroRNA-155 promotes myocardial infarction-induced apoptosis by targeting RNA-binding protein QKI. Oxid. Med. Cell. Longev 2019, 4579806 (2019). 31191799 PMC6525929
  171. [180]Hanna J, Hossain GS, Kocerha J, The potential for microRNA therapeutics and clinical research. Front. Genet 10, 478 (2019). 31156715 PMC6532434
  172. [181]Juliano RL, The delivery of therapeutic oligonucleotides. Nucleic Acids Res. 44, 6518– 6548 (2016). 27084936 PMC5001581
  173. [183]Lennox KA, Behlke MA, Chemical modification and design of anti-miRNA oligonucleotides. Gene Ther. 18, 1111– 1120 (2011). 21753793
  174. [184]Meister G, Landthaler M, Dorsett Y, Tuschl T, Sequence-specific inhibition of microRNA-and siRNA-induced RNA silencing. RNA 10, 544– 550 (2004). 14970398 PMC1370948
  175. [185]Krützfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, Manoharan M, Stoffel M, Silencing of microRNAs in vivo with “antagomirs”. Nature 438, 685– 689 (2005). 16258535
  176. [186]Vickers TA, Wyatt JR, Burckin T, Bennett CF, Freier SM, Fully modified 2′ MOE oligonucleotides redirect polyadenylation. Nucleic Acids Res. 29, 1293– 1299 (2001). 11238995 PMC29745
  177. [187]Elmén J, Lindow M, Silahtaroglu A, Bak M, Christensen M, Lind-Thomsen A, Hedtjärn M, Hansen JB, Hansen HF, Straarup EM, Cullagh KM, Kearney P, Kauppinen S, Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver. Nucleic Acids Res. 36, 1153– 1162 (2008). 18158304 PMC2275095
  178. [188]Obad S, dos Santos CO, Petri A, Heidenblad M, Broom O, Ruse C, Fu C, Lindow M, Stenvang J, Straarup EM, Hansen HF, Koch T, Pappin D, Hannon GJ, Kauppinen S, Silencing of microRNA families by seed-targeting tiny LNAs. Nat. Genet 43, 371– 380 (2011). 21423181 PMC3541685
  179. [189]Ebert MS, Neilson JR, Sharp PA, MicroRNA sponges: Competitive inhibitors of small RNAs in mammalian cells. Nat. Methods 4, 721– 726 (2007). 17694064 PMC3857099
  180. [190]Ebert MS, Sharp PA, MicroRNA sponges: Progress and possibilities. RNA 16, 2043– 2050 (2010). 20855538 PMC2957044
  181. [191]Keeley EC, Boura JA, Grines CL, Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review of 23 randomised trials. Lancet 361, 13– 20 (2003). 12517460
  182. [192]Foinquinos A, Batkai S, Genschel C, Viereck J, Rump S, Gyöngyösi M, Traxler D, Riesenhuber M, Spannbauer A, Lukovic D, Weber N, Zlabinger K, Hašimbegović E, Winkler J, Fiedler J, Dangwal S, Fischer M, de la Roche J, Wojciechowski D, Kraft T, Garamvölgyi R, Neitzel S, Chatterjee S, Yin X, Bär C, Mayr M, Xiao K, Thum T, Preclinical development of a miR-132 inhibitor for heart failure treatment. Nat. Commun 11, 633 (2020). 32005803 PMC6994493
  183. [195]Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee JJ, Lötvall JO, Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol 9, 654– 659 (2007). 17486113
  184. [196]Bian S, Zhang L, Duan L, Wang X, Min Y, Yu H, Extracellular vesicles derived from human bone marrow mesenchymal stem cells promote angiogenesis in a rat myocardial infarction model. J. Mol. Med. (Berl) 92, 387– 397 (2014). 24337504
  185. [197]Liu B, Lee BW, Nakanishi K, Villasante A, Williamson R, Metz J, Kim J, Kanai M, Bi L, Brown K, Di Paolo G, Homma S, Sims PA, Topkara VK, Vunjak-Novakovic G, Cardiac recovery via extended cell-free delivery of extracellular vesicles secreted by cardiomyocytes derived from induced pluripotent stem cells. Nat. Biomed. Eng 2, 293– 303 (2018). 30271672 PMC6159913
  186. [198]Gallet R, Dawkins J, Valle J, Simsolo E, de Couto G, Middleton R, Tseliou E, Luthringer D, Kreke M, Smith RR, Marbán L, Ghaleh B, Marbán E, Exosomes secreted by cardiosphere-derived cells reduce scarring, attenuate adverse remodelling, and improve function in acute and chronic porcine myocardial infarction. Eur. Heart J 38, 201– 211 (2017). 28158410 PMC5837390
  187. [199]Pachler K, Lener T, Streif D, Dunai ZA, Desgeorges A, Feichtner M, Öller M, Schallmoser K, Rohde E, Gimona M, A good manufacturing practice–grade standard protocol for exclusively human mesenchymal stromal cell–derived extracellular vesicles. Cytotherapy 19, 458– 472 (2017). 28188071
  188. [200]Chen Y, Zhao Y, Chen W, Xie L, Zhao Z-A, Yang J, Chen Y, Lei W, Shen Z, MicroRNA-133 overexpression promotes the therapeutic efficacy of mesenchymal stem cells on acute myocardial infarction. Stem Cell Res. Ther 8, 268 (2017). 29178928 PMC5702098
  189. [201]Morishita M, Takahashi Y, Nishikawa M, Takakura Y, Pharmacokinetics of exosomes—an important factor for elucidating the biological roles of exosomes and for the development of exosome-based therapeutics. J. Pharm. Sci 106, 2265– 2269 (2017). 28283433
  190. [203]Springer AD, Dowdy SF, GalNAc-siRNA conjugates: Leading the way for delivery of RNAi therapeutics. Nucleic Acid Ther. 28, 109– 118 (2018). 29792572 PMC5994659
  191. [204]Mentkowski KI, Lang JK, Exosomes engineered to express a cardiomyocyte binding peptide demonstrate improved cardiac retention in vivo. Sci. Rep 9, 10041 (2019). 31296886 PMC6624248
  192. [205]Xue X, Shi X, Dong H, You S, Cao H, Wang K, Wen Y, Shi D, He B, Li Y, Delivery of microRNA-1 inhibitor by dendrimer-based nanovector: An early targeting therapy for myocardial infarction in mice. Nanomedicine 14, 619– 631 (2018). 29269324
  193. [206]Sugo T, Terada M, Oikawa T, Miyata K, Nishimura S, Kenjo E, Ogasawara-Shimizu M, Makita Y, Imaichi S, Murata S, Otake K, Kikuchi K, Teratani M, Masuda Y, Kamei T, Takagahara S, Ikeda S, Ohtaki T, Matsumoto H, Development of antibody-siRNA conjugate targeted to cardiac and skeletal muscles. J. Control. Release 237, 1– 13 (2016). 27369865
  194. [207]Liu M, Li M, Sun S, Li B, Du D, Sun J, Cao F, Li H, Jia F, Wang T, Chang N, Yu H, Wang Q, Peng H, The use of antibody modified liposomes loaded with AMO-1 to deliver oligonucleotides to ischemic myocardium for arrhythmia therapy. Biomaterials 35, 3697– 3707 (2014). 24468403
  195. [208]Cuellar TL, Barnes D, Nelson C, Tanguay J, Yu S-F, Wen X, Scales SJ, Gesch J, Davis D, van Brabant Smith A, Leake D, Vandlen R, Siebel CW, Systematic evaluation of antibody-mediated siRNA delivery using an industrial platform of THIOMAB-siRNA conjugates. Nucleic Acids Res. 43, 1189– 1203 (2015). 25550431 PMC4333408
  196. [209]Juliano RL, Ming X, Carver K, Laing B, Cellular uptake and intracellular trafficking of oligonucleotides: Implications for oligonucleotide pharmacology. Nucleic Acid Ther. 24, 101– 113 (2014). 24383421 PMC3962645
  197. [210]LÖnn P, Kacsinta AD, Cui XS, Hamil AS, Kaulich M, Gogoi K, Dowdy SF, Enhancing endosomal escape for intracellular delivery of macromolecular biologic therapeutics. Sci. Rep 6, 32301 (2016). 27604151 PMC5015074
  198. [211]Gilleron J, Querbes W, Zeigerer A, Borodovsky A, Marsico G, Schubert U, Manygoats K, Seifert S, Andree C, StÖter M, Epstein-Barash H, Zhang L, Koteliansky V, Fitzgerald K, Fava E, Bickle M, Kalaidzidis Y, Akinc A, Maier M, Zerial M, Image-based analysis of lipid nanoparticle-mediated siRNA delivery, intracellular trafficking and endosomal escape. Nat. Biotechnol 31, 638– 646 (2013). 23792630
  199. [212]Dominska M, Dykxhoorn DM, Breaking down the barriers: siRNA delivery and endosome escape. J. Cell Sci 123, 1183– 1189 (2010). 20356929
  200. [213]Stessl M, Noe CR, Winkler J, in From Nucleic Acids Sequences to Molecular Medicine, Erdmann VA, Barciszewski J, Eds. (Springer Berlin Heidelberg, 2012), pp. 67– 83.

200 of 281 shown

Cited by

Sorted by citations

Authors
Liu, B., Wang, B., Zhang, X., Lock, R., Nash, T., & Vunjak-Novakovic, G.
Venue
Science Translational Medicine
Publisher
American Association for the Advancement of Science (AAAS)
Published
2021-02-10
Volume
13
Issue
580
ISSN
  • 1946-6234
  • 1946-6242
DOI
10.1126/scitranslmed.abd0914
PMC
PMC8848299
Cited by
48
References
14
Language
en
Funders
  • NIH Office of the Director (EB025765, EB027062, HL076485, GM00736, HL145921)
  • NSF Office of the Director (16478)
  • New York State Department of Health - Wadsworth Center (C32606GG)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review